Probiotic supplementation for respiratory and gastrointestinal illness symptoms in healthy physically active individuals

Clinical Nutrition

Volumn 33, Issue 4, 2014, Pages 581-587

  West, Nicholas P ^a   Horn, Peggy L ^b   Pyne, David B ^a,b,c   Gebski, Val J ^d   Lahtinen, Sampo J ^e   Fricker, Peter A ^b   Cripps, Allan W ^a  

^a GRIFFITH UNIVERSITY   (Australia)

^b AUSTRALIAN INSTITUTE OF SPORT   (Australia)

^c The Australian National University   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

^e Danisco Finland Oy   (Finland)

Author keywords

Bifidobacterium animalis Subsp. lactis Bi 07; Bifidobacterium animalis Subsp. lactis Bl 04; Healthy adults; Lactobacillus acidophilus NCFM; Probiotics; Respiratory illness

Indexed keywords

ANTIBIOTIC AGENT; PLACEBO; PROBIOTIC AGENT;

ADULT; ARTICLE; BIFIDOBACTERIUM ANIMALIS; COLONY FORMING UNIT; CONTROLLED STUDY; COPING BEHAVIOR; DIET SUPPLEMENTATION; DISEASE DURATION; DOUBLE BLIND PROCEDURE; DRUG USE; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; INFECTION RISK; LACTOBACILLUS ACIDOPHILUS; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PHYSICAL ACTIVITY; PROFESSIONAL PRACTICE; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; UPPER RESPIRATORY TRACT INFECTION; BIFIDOBACTERIUM; BODY MASS; GASTROINTESTINAL DISEASES; MIDDLE AGED; MOTOR ACTIVITY; NEW ZEALAND; NORMAL HUMAN; YOUNG ADULT;

ADULT; BIFIDOBACTERIUM; BODY MASS INDEX; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; GASTROINTESTINAL DISEASES; HEALTHY VOLUNTEERS; HUMANS; LACTOBACILLUS ACIDOPHILUS; MALE; MIDDLE AGED; MOTOR ACTIVITY; NEW ZEALAND; PROBIOTICS; YOUNG ADULT;

EID: 84902376766     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2013.10.002     Document Type: Article

References (31)

1. Britt H., Miller G.C., Charles J., Henderson J., Bayram C., Pan Y., et al. General practice activity in Australia 2009-10 2010, General practice series no. 27.
2. Moyad M.A. Conventional and alternative medical advice for cold and flu prevention: what should be recommended and what should be avoided?. Urol Nurs 2009 Nov-Dec, 29(6):455-458.
3. Davis G. Social and economic costs of influenza 2010, Online article, [accessed 11.08.11]. http://www.risklogic.com.au/2010/10/social%20and%20economic%20costs%20of%20influenza.
4. Newman L., Stirzaker S., Knuckey D., Robinson K., Hood J., Knope K., et al. Australia's notifiable disease status, 2008: annual report of the national notifiable diseases surveillance system. Commun Dis Intell Q Rep 2010 Sep, 34(3):157-224.
5. Hao Q., Lu Z., Dong B.R., Huang C.Q., Wu T. Probiotics for preventing acute upper respiratory tract infections. Cochrane Database Syst Rev 2011, 9:CD006895.
6. West N.P., Pyne D.B., Peake J.M., Cripps A.W. Probiotics, immunity and exercise: a review. Exerc Immunol Rev 2009, 15:107-126.
7. Timmerman H.M., Koning C.J., Mulder L., Rombouts F.M., Beynen A.C. Monostrain, multistrain and multispecies probiotics-A comparison of functionality and efficacy. Int J Food Microbiol 2004 Nov 15, 96(3):219-233.
8. Leyer G.J., Li S., Mubasher M.E., Reifer C., Ouwehand A.C. Probiotic effects on cold and influenza-like symptom incidence and duration in children. Pediatrics 2009 Aug, 124(2):e172-e179.
9. Makino S., Ikegami S., Kume A., Horiuchi H., Sasaki H., Orii N. Reducing the risk of infection in the elderly by dietary intake of yoghurt fermented with Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1. Br J Nutr 2010 Oct, 104(7):998-1006.
10. Berggren A., Lazou Ahren I., Larsson N., Onning G. Randomised, double-blind and placebo-controlled study using new probiotic lactobacilli for strengthening the body immune defence against viral infections. Eur J Nutr 2011 Apr, 50(3):203-210.
11. Gleeson M., Bishop N.C., Oliveira M., Tauler P. Daily probiotic's (Lactobacillus casei Shirota) reduction of infection incidence in athletes. Int J Sport Nutr Exerc Metab 2011 Feb, 21(1):55-64.
12. Garber C.E., Blissmer B., Deschenes M.R., Franklin B.A., Lamonte M.J., Lee I.M., et al. American college of sports medicine position stand. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise. Med Sci Sports Exerc 2011 Jul, 43(7):1334-1359.
13. Gleeson M., Bishop N.C., Stensel D.J., Lindley M.R., Mastana S.S., Nimmo M.A. The anti-inflammatory effects of exercise: mechanisms and implications for the prevention and treatment of disease. Nat Rev Immunol 2011 Sep, 11(9):607-615.
14. Szakaly Z., Szente V., Kover G., Polereczki Z., Szigeti O. The influence of lifestyle on health behavior and preference for functional foods. Appetite 2011 Nov 15, 58(1):406-413.
15. Paineau D., Carcano D., Leyer G., Darquy S., Alyanakian M.A., Simoneau G., et al. Effects of seven potential probiotic strains on specific immune responses in healthy adults: a double-blind, randomized, controlled trial. FEMS Immunol Med Microbiol 2008 Jun, 53(1):107-113.
16. Larsen C.N., Nielsen S., Kaestel P., Brockmann E., Bennedsen M., Christensen H.R., et al. Dose-response study of probiotic bacteria Bifidobacterium animalis subsp lactis BB-12 and Lactobacillus paracasei subsp paracasei CRL-341 in healthy young adults. Eur J Clin Nutr 2006 Nov, 60(11):1284-1293.
17. Campbell-Sills L., Stein M.B. Psychometric analysis and refinement of the connor-davidson resilience scale (CD-RISC): validation of a 10-item measure of resilience. JTrauma Stress 2007 Dec, 20(6):1019-1028.
18. West N.P., Pyne D.B., Cripps A.W., Hopkins W.G., Eskesen D.C., Jairath A., et al. Lactobacillus fermentum (PCC(R)) supplementation and gastrointestinal and respiratory-tract illness symptoms: a randomised control trial in athletes. Nutr J 2011, 10:30.
19. Gwaltney J.M. Viral respiratory infection therapy: historical perspectives and current trials. Am J Med 2002 Apr 22, 112(Suppl.6A):33S-41S.
20. Heritier S., Gebski V., Pillai A. Dynamic balancing randomization in controlled clinical trials. Stat Med 2005 Dec 30, 24(24):3729-3741.
21. Falsey A.R. Respiratory syncytial virus infection in adults. Semin Respir Crit Care Med 2007 Apr, 28(2):171-181.
22. Abd ElHafeez S., Torino C., D'Arrigo G., Bolignano D., Provenzano F., Mattace-Raso F., et al. An overview on standard statistical methods for assessing exposure-outcome link in survival analysis (Part II): the Kaplan-Meier analysis and the cox regression method. Aging Clin Exp Res 2012 Jun, 24(3):203-206.
23. Wei L.J., Lin D.Y., Weissfield L. Regressionanalysis of multivariate incomplete failure time data. JAm Stat Assoc 1989, 84:1065-1073.
24. Wei L.J., Johnson W.E. Combining dependent tests with incomplete repeated measurements. Biometrika 1985, 72(2):359-364.
25. Stel V.S., Dekker F.W., Tripepi G., Zoccali C., Jager K.J. Survival analysis I: the Kaplan-Meier method. Nephron Clin Pract 2011, 119(1):c83-c88.
26. Gleeson M., Walsh N.P. The BASES expert statement on exercise, immunity, and infection. JSports Sci 2012, 30(3):321-324.
27. Walsh N.P., Gleeson M., Shephard R.J., Woods J.A., Bishop N.C., Fleshner M., et al. Position statement. Part one: immune function and exercise. Exerc Immunol Rev 2011, 17:6-63.
28. Walsh N.P., Gleeson M., Pyne D.B., Nieman D.C., Dhabhar F.S., Shephard R.J., et al. Position statement. Part two: maintaining immune health. Exerc Immunol Rev 2011, 17:64-103.
29. Besselink M.G., Timmerman H.M., Buskens E., Nieuwenhuijs V.B., Akkermans L.M., Gooszen H.G. Probiotic prophylaxis in patients with predicted severe acute pancreatitis (PROPATRIA): design and rationale of a double-blind, placebo-controlled randomised multicenter trial [ISRCTN38327949]. BMC Surg 2004, 4:12.
30. de Vrese M., Winkler P., Rautenberg P., Harder T., Noah C., Laue C., et al. Effect of Lactobacillus gasseri PA 16/8, Bifidobacterium longum SP 07/3, B. bifidum MF 20/5 on common cold episodes: a double blind, randomized, controlled trial. Clin Nutr 2005 Aug, 24(4):481-491.
31. Hemila H., Chalker E. Vitamin C for preventing and treating the common cold. Cochrane Database Syst Rev 2013, 1:CD000980.